NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email /PRNewswire/ — Global equity capital markets staged a recovery in 2025, with issuance rising 25 percent year-on-year to USD 957.2 billion, according to the…Read More